Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Vertex and Witkowski Partnership

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Feb 20, 2022 7:33pm

172 Views

Post# 34446946

RE:RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership

It was created on 2017-06-21 but is still relevant and agree it's a positive for SVA. Not so with stem cells. Once you put them in, thats it. You cant withdraw them. Theres no kill switch. Sigilon is a good example of another problem that could arise and reason beyond cancer of why these cells should be easy to remove. The immune system could start to recognize and attack the insulin produced by Vertex's iPSC cells.

BioTeck wrote: Not sure how old this article is but a positive for SVA until vertex announces their device. https://www.hopkinsmedicine.org/stem_cell_research/safety_ethics/are_induced_pluripotent_stem_cells_safe_yet.html
MustangSalley wrote:
Bio,

Where did they prove there is no concerns about no concerns for tumours ? The premise of a device is so that the cells maybe be retrievable because in the past stem cells went to areas and caused tumours . Vertex is dumping preembryonic cells in the portal vein . There is insulin independence but we don't know for how long .

I believe the race will be between Vertex and Sva in the end . Your insertion that Vertex could buy Sva will only happen if they need a device and time will tell.

Ms Sally ... no lidocaine needed